FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Michael Crump

Research Profile

Procedures

Concepts & Ideas

Disorders

Chemicals & Drugs

Phenomena

Recurrence

Co-author Network

Publications

TOP 3
D Villa; T Panzarella; Michael Crump; B Feng; A Keating; John Kuruvilla
Outcome of patients with transformed indolent non-Hodgkin lymphoma referred for autologous stem-cell transplantation.
Diego Villa; Anargyros Xenocostas; Abdulwahab Al-Tourah; Mohsen Alzahrani; Kimberley Ambler; Rena Buckstein; Neil Chua; Sandra Cohen; Joseph M Connors; Felix Couture; Michael Crump; Ronan Foley; Jean-François Larouche; Christina Lee; David A MacDonald; Alexandra Muccilli; Tony Panzarella; Khaled M Ramadan; Morel Rubinger; Mitchell Sabloff; Kerry J Savage; Douglas A Stewart; Cynthia L Toze; John Kuruvilla
Autologous and allogeneic stem-cell transplantation for transformed follicular lymphoma: a report of the Canadian blood and marrow transplant group.
Jayant S Goda; Mary K Gospodarowicz; David C Hodgson; Armand Keating; John Kuruvilla; Christine Massey; Alexander Sun; Michael Crump; Woodrow Wells; Richard W Tsang
Role of salvage radiation therapy for patients with relapsed or refractory hodgkin lymphoma who failed autologous stem cell transplant.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Michael Crump (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: D Villa; T Panzarella; Michael Crump; B Feng; A Keating; John Kuruvilla
Outcome of patients with transformed indolent non-Hodgkin lymphoma referred for autologous stem-cell transplantation.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2013;24(6):1603-9.
2013: Diego Villa; Anargyros Xenocostas; Abdulwahab Al-Tourah; Mohsen Alzahrani; Kimberley Ambler; Rena Buckstein; Neil Chua; Sandra Cohen; Joseph M Connors; Felix Couture; Michael Crump; Ronan Foley; Jean-François Larouche; Christina Lee; David A MacDonald; Alexandra Muccilli; Tony Panzarella; Khaled M Ramadan; Morel Rubinger; Mitchell Sabloff; Kerry J Savage; Douglas A Stewart; Cynthia L Toze; John Kuruvilla
Autologous and allogeneic stem-cell transplantation for transformed follicular lymphoma: a report of the Canadian blood and marrow transplant group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013;31(9):1164-71.
2012: Jayant S Goda; Mary K Gospodarowicz; David C Hodgson; Armand Keating; John Kuruvilla; Christine Massey; Alexander Sun; Michael Crump; Woodrow Wells; Richard W Tsang
Role of salvage radiation therapy for patients with relapsed or refractory hodgkin lymphoma who failed autologous stem cell transplant.
International journal of radiation oncology, biology, physics 2012;84(3):e329-35.
2012: Michael Crump
Toward risk-based breast cancer screening and prevention strategies for survivors of Hodgkin's lymphoma: one step closer?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(22):2712-4.
2012: Laurie H Sehn; Douglas A Stewart; Sarit E Assouline; David J Carlile; Gregg Fine; Susan Frances-Lasserre; Randy D Gascoyne; Joy Mangel; Michael Crump
A phase 1 study of obinutuzumab induction followed by 2 years of maintenance in patients with relapsed CD20-positive B-cell malignancies.
Blood 2012;119(22):5118-25.
2012: Michael Crump
Hitting the target in MCL.
Blood 2012;119(20):4580-1.
2012: Diego Villa; Michael Crump; Armand Keating; Christine Massey; Noemi Puig; Tara Seshadri; Richard Tsang; John Kuruvilla
Second-line salvage chemotherapy for transplant-eligible patients with Hodgkin's lymphoma resistant to platinum-containing first-line salvage chemotherapy.
Haematologica 2012;97(5):751-7.
2012: David Telio; Richard Tsang; Clement Ma; Michael Crump; Kim Fernandes; Armand Keating; John Kuruvilla
Salvage chemotherapy and autologous stem cell transplant in primary refractory diffuse large B-cell lymphoma: outcomes and prognostic factors.
Leukemia & lymphoma 2012;53(5):836-41.
2012: Ralph M Meyer; Robert G Pearcey; Lois E Shepherd; Chaim Shustik; Douglas A Stewart; Woodrow A Wells; Jane N Winter; Bingshu E Chen; Joseph Michael Connors; Michael Crump; A Rashid Dar; Marina Djurfeldt; Mary K Gospodarowicz; Sandra J Horning
ABVD alone versus radiation-based therapy in limited-stage Hodgkin's lymphoma.
The New England journal of medicine 2012;366(5):399-408.
2011: N Puig; T Seshadri; K al-Farsi; N Franke; Armand Keating; John Kuruvilla; Melania Pintilie; Michael Crump
High-dose chemotherapy and auto-SCT in elderly patients with Hodgkin's lymphoma.
Bone marrow transplantation 2011;46(10):1339-44.
2011: Laurie H Sehn; Lois Shepherd; Jonathan Sussman; Sanraj Basi; Guy Cantin; Bingshu E Chen; Stephen Couban; Marina Djurfeldt; Randy D Gascoyne; Kevin Imrie; Bernard Lemieux; David MacDonald; Sheldon Rubin; Morel Rubinger; Michael Crump
Bortezomib ADDED to R-CVP is safe and effective for previously untreated advanced-stage follicular lymphoma: a phase II study by the National Cancer Institute of Canada Clinical Trials Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(25):3396-401.
2011: Donald A Berry; Pierre Biron; Marco Bregni; Jean Caputo; John P Crown; Michael Crump; Marcella M Johnson; Xiudong Lei; Jean-Pierre Lotz; Giovanni Rosti; Peter Schmid; Dori A Smith; Edward A Stadtmauer; Naoto T Ueno; Linda J Yancey; Taner Demirer
High-dose chemotherapy with autologous hematopoietic stem-cell transplantation in metastatic breast cancer: overview of six randomized trials.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(24):3224-31.
2011: Rena Buckstein; John Kuruvilla; Neil Chua; Christina Lee; David A Macdonald; Abdulwahab J Al-Tourah; Alison H Foo; Wendy Walsh; Michael Crump; S Percy Ivy; Elizabeth A Eisenhauer
Sunitinib in relapsed or refractory diffuse large B-cell lymphoma: a clinical and pharmacodynamic phase II multicenter study of the NCIC Clinical Trials Group.
Leukemia & lymphoma 2011;52(5):833-41.
2011: John Kuruvilla; Armand Keating; Michael Crump
How I treat relapsed and refractory Hodgkin lymphoma.
Blood 2011;117(16):4208-17.
2011: C Tom Kouroukis; Louis A V Fernandez; Michael Crump; Neil Sun Chua; Rena Buckstein; Robert Turner; Sarit Assouline; Richard J Klasa; Wendy Walsh; Jean Powers; Randy D Gascoyne; Elizabeth Eisenhauer
A phase II study of bortezomib and gemcitabine in relapsed mantle cell lymphoma from the National Cancer Institute of Canada Clinical Trials Group (IND 172).
Leukemia & lymphoma 2011;52(3):394-9.
2010: David Telio; Denis Bailey; Christine Chen; Michael Crump; Donna Reece; Vishal Kukreti
Two distinct syndromes of lymphoma-associated AL amyloidosis: a case series and review of the literature.
American journal of hematology 2010;85(10):805-8.
2010: Noemi Puig; Melania Pintilie; Tara Seshadri; Khalil Al-Farsi; Tracy Nagy; Norman Franke; Richard Tsang; Armand Keating; Michael Crump; John Kuruvilla
Different response to salvage chemotherapy but similar post-transplant outcomes in patients with relapsed and refractory Hodgkin's lymphoma.
Haematologica 2010;95(9):1496-502.
2010: Jayant S Goda; Mary Gospodarowicz; Melania Pintilie; Woodrow Wells; David C Hodgson; Alexander Sun; Michael Crump; Richard W Tsang
Long-term outcome in localized extranodal mucosa-associated lymphoid tissue lymphomas treated with radiotherapy.
Cancer 2010;116(16):3815-24.
2010: Lawrence Marks; Constance Cirrincione; Thomas J Fitzgerald; Fran Laurie; Arvin S Glicksman; James Vredenburgh; Leonard R Prosnitz; Elizabeth J Shpall; Michael Crump; Paul G Richardson; Michael W Schuster; Jinli Ma; Bercedis L Peterson; Larry Norton; Steven Seagren; I Craig Henderson; David D Hurd; William P Peters
Impact of high-dose chemotherapy on the ability to deliver subsequent local-regional radiotherapy for breast cancer: analysis of Cancer and Leukemia Group B Protocol 9082.
International journal of radiation oncology, biology, physics 2010;76(5):1305-13.
2010: Michael Crump; David Hedley; Suzanne Kamel-Reid; Brian Leber; Richard Wells; Joseph Brandwein; Rena Buckstein; Janine Kassis; Mark Minden; John Matthews; Sue Robinson; Robert Turner; Lynn McIntosh; Elizabeth Eisenhauer; Lesley Seymour
A randomized phase I clinical and biologic study of two schedules of sorafenib in patients with myelodysplastic syndrome or acute myeloid leukemia: a NCIC (National Cancer Institute of Canada) Clinical Trials Group Study.
Leukemia & lymphoma 2010;51(2):252-60.
2010: Linh T Nguyen; Pei Hua Yen; Jessica Nie; Nicole Liadis; Danny Ghazarian; Ayman Al-Habeeb; Alexandra Easson; Wey Leong; Joan E Lipa; David McCready; Michael Reedijk; David Hogg; Anthony M Joshua; Ian Quirt; Hans Messner; Patricia Shaw; Michael Crump; Eran Sharon; Pamela S Ohashi
Expansion and characterization of human melanoma tumor-infiltrating lymphocytes (TILs).
PloS one 2010;5(11):e13940.
2009: Tara Seshadri; Melania Pintilie; John Kuruvilla; Armand Keating; Richard Tsang; Sahar Zadeh; Michael Crump
Incidence and risk factors for second cancers after autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma.
Leukemia & lymphoma 2009;50(3):380-6.
2009: M A Trinkaus; Stephen E Lapinsky; Michael Crump; Armand Keating; Donna Reece; C Chen; David Hallett; N Franke; A Winter; J R Mikhael
Predictors of mortality in patients undergoing autologous hematopoietic cell transplantation admitted to the intensive care unit.
Bone marrow transplantation 2009;43(5):411-5.
2008: T Seshadri; J Stakiw; Melania Pintilie; Armand Keating; Michael Crump; John Kuruvilla
Utility of subsequent conventional dose chemotherapy in relapsed/refractory transplant-eligible patients with diffuse large B-cell lymphoma failing platinum-based salvage chemotherapy.
Hematology (Amsterdam, Netherlands) 2008;13(5):261-6.
2008: Sten Myrehaug; Melania Pintilie; Richard Tsang; Robert Mackenzie; Michael Crump; Zhongliang Chen; Alexander Sun; David C Hodgson
Cardiac morbidity following modern treatment for Hodgkin lymphoma: supra-additive cardiotoxicity of doxorubicin and radiation therapy.
Leukemia & lymphoma 2008;49(8):1486-93.
2008: John Kuruvilla; Melania Pintilie; Richard Tsang; Tracy Nagy; Armand Keating; Michael Crump
Salvage chemotherapy and autologous stem cell transplantation are inferior for relapsed or refractory primary mediastinal large B-cell lymphoma compared with diffuse large B-cell lymphoma.
Leukemia & lymphoma 2008;49(7):1329-36.
2008: T Seshadri; Melania Pintilie; Armand Keating; Michael Crump; John Kuruvilla
The relationship between absolute lymphocyte count with PFS in patients with Hodgkin's lymphoma undergoing autologous hematopoietic cell transplant.
Bone marrow transplantation 2008;42(1):29-34.
2008: Michael Crump; Bertrand Coiffier; E D Jacobsen; L Sun; J L Ricker; H Xie; S R Frankel; S S Randolph; B D Cheson
Phase II trial of oral vorinostat (suberoylanilide hydroxamic acid) in relapsed diffuse large-B-cell lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(5):964-9.
2008: Tara Seshadri; John Kuruvilla; Michael Crump; Armand Keating
Salvage therapy for relapsed/refractory diffuse large B cell lymphoma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(3):259-67.
2008: Michael Crump; Stefan Gluck; Dongsheng Tu; Doug Stewart; Mark Levine; Peter Kirkbride; Janet Dancey; Susan O'Reilly; Tsiporah Shore; Stephen Couban; Caroline Girouard; Susan Marlin; Lois Shepherd; Kathleen I Pritchard
Randomized trial of high-dose chemotherapy with autologous peripheral-blood stem-cell support compared with standard-dose chemotherapy in women with metastatic breast cancer: NCIC MA.16.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(1):37-43.
2008: L Lee; Melania Pintilie; David C Hodgson; P E Goss; Michael Crump
Screening mammography for young women treated with supradiaphragmatic radiation for Hodgkin's lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(1):62-7.
2007: Carlo Bastianutto; Asim Mian; Julie Symes; Joseph D Mocanu; Nehad M Alajez; Gillian Sleep; Wei Shi; Armand Keating; Michael Crump; Mary Gospodarowicz; Jeffrey A Medin; Mark D Minden; Fei-Fei Liu
Local radiotherapy induces homing of hematopoietic stem cells to the irradiated bone marrow.
Cancer research 2007;67(21):10112-6.
2007: Sarit Assouline; Ralph M Meyer; Claire Infante-Rivard; Joseph Michael Connors; Andrew R Belch; Michael Crump; C Tom Kouroukis; Elizabeth Eisenhauer
Development of adapted RECIST criteria to assess response in lymphoma and their comparison to the International Workshop Criteria.
Leukemia & lymphoma 2007;48(3):513-20.
2007: David C Hodgson; Melania Pintilie; Leah Gitterman; Beth Dewitt; Carol-Ann Buckley; Sameera Ahmed; Katherine Smith; Amanda Schwartz; Richard W Tsang; Michael Crump; Woodrow Wells; Alexander Sun; Mary K Gospodarowicz
Fertility among female hodgkin lymphoma survivors attempting pregnancy following ABVD chemotherapy.
Hematological oncology 2007;25(1):11-5.
2007: Andrew R Belch; C Tom Kouroukis; Michael Crump; Laurie H Sehn; Randy D Gascoyne; Richard J Klasa; Jean Powers; J Wright; E A Eisenhauer
A phase II study of bortezomib in mantle cell lymphoma: the National Cancer Institute of Canada Clinical Trials Group trial IND.150.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(1):116-21.
2006: Rena Buckstein; Robert S Kerbel; Yuval Shaked; Rakesh Nayar; Cindy Foden; Ruth Turner; Christina Lee; Diane Taylor; Liying Zhang; Shan Man; Sylvain Baruchel; Diana Stempak; Francesco Bertolini; Michael Crump
High-Dose celecoxib and metronomic "low-dose" cyclophosphamide is an effective and safe therapy in patients with relapsed and refractory aggressive histology non-Hodgkin's lymphoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(17):5190-8.
2006: Richard W Tsang; David C Hodgson; Michael Crump
Hodgkin's lymphoma.
Current problems in cancer 2006;30(3):107-58.
2006: Chandra Martens; David C Hodgson; Woodrow A Wells; Alexander Sun; Andrea Bezjak; Melania Pintilie; Michael Crump; Mary K Gospodarowicz; Richard Tsang
Outcome of hyperfractionated radiotherapy in chemotherapy-resistant non-Hodgkin's lymphoma.
International journal of radiation oncology, biology, physics 2006;64(4):1183-7.
2006: Chul Ha; L Jeffrey Medeiros; Chusilp Charnsangavej; Michael Crump; Mary K Gospodarowicz
Lymphoma.
Radiographics : a review publication of the Radiological Society of North America, Inc 2006;26(2):607-20.
2006: John Kuruvilla; Kevin Song; Peter Mollee; Tony Panzarella; Jan McCrae; Tracy Nagy; Michael Crump; Armand Keating
A phase II study of thalidomide and vinblastine for palliative patients with Hodgkin's lymphoma.
Hematology (Amsterdam, Netherlands) 2006;11(1):25-9.
2006: John Kuruvilla; Tracy Nagy; Melania Pintilie; Richard Tsang; Armand Keating; Michael Crump
Similar response rates and superior early progression-free survival with gemcitabine, dexamethasone, and cisplatin salvage therapy compared with carmustine, etoposide, cytarabine, and melphalan salvage therapy prior to autologous stem cell transplantation for recurrent or refractory Hodgkin lymphoma.
Cancer 2006;106(2):353-60.
2005: Michael Crump; Lois Shepherd; Boris Lin
A randomized phase III study of gemcitabine, dexamethasone, and cisplatin versus dexamethasone, cytarabine, and cisplatin as salvage chemotherapy followed by posttransplantation rituximab maintenance therapy versus observation for treatment of aggressive B-Cell and T-Cell non-Hodgkin's lymphoma.
Clinical lymphoma 2005;6(1):56-60.
2005: Kevin W Song; Peter Mollee; Donna E Hogge; Vikas Gupta; Michael J Barnett; Donna L Forrest; Julye C Lavoie; Thomas J Nevill; Stephen H Nantel; John D Shepherd; Clay A Smith; Heather J Sutherland; Cynthia L Toze; Michael Crump; Armand Keating
Predictive value of karyotype on outcome of autotransplants for acute myeloid leukemia in second remission.
Leukemia & lymphoma 2005;46(4):525-31.
2005: Carol A Sawka; Frances A Shepherd; Edmee Franssen; Joseph Brandwein; Dale A Dotten; Jean-Pierre G Routy; Irwin R Walker; Jean St-Louis; Marianne Taylor; Karen Arts; Michael Crump; MaryAnn Foote
A prospective, non-randomised phase 1-2 trial of VACOP-B with filgrastim support for HIV-related non-Hodgkin's lymphoma.
Biotechnology annual review 2005;11():381-9.
2004: Alan Tinmouth; Ian F Tannock; Michael Crump; George Tomlinson; Joseph Brandwein; Mark D Minden; David Sutton
Low-dose prophylactic platelet transfusions in recipients of an autologous peripheral blood progenitor cell transplant and patients with acute leukemia: a randomized controlled trial with a sequential Bayesian design.
Transfusion 2004;44(12):1711-9.
2004: Michael Crump; Tara Baetz; Stephen Couban; Andrew R Belch; Deborah Marcellus; Kang Howson-Jan; Kevin Imrie; Robert Myers; Grenfell Adams; Keyue Ding; Nancy Paul; Lois Shepherd; Jose Iglesias; Ralph Meyer
Gemcitabine, dexamethasone, and cisplatin in patients with recurrent or refractory aggressive histology B-cell non-Hodgkin lymphoma: a Phase II study by the National Cancer Institute of Canada Clinical Trials Group (NCIC-CTG).
Cancer 2004;101(8):1835-42.
2004: Peter Mollee; Vikas Gupta; Kevin Song; V Reddy; N Califaretti; Richard Tsang; Michael Crump; Armand Keating
Long-term outcome after intensive therapy with etoposide, melphalan, total body irradiation and autotransplant for acute myeloid leukemia.
Bone marrow transplantation 2004;33(12):1201-8.
2004: Joy Mangel; H A Leitch; Joseph Michael Connors; Rena Buckstein; Kevin Imrie; David E Spaner; Michael Crump; Nancy Pennell; Angela Boudreau; Neil L Berinstein
Intensive chemotherapy and autologous stem-cell transplantation plus rituximab is superior to conventional chemotherapy for newly diagnosed advanced stage mantle-cell lymphoma: a matched pair analysis.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(2):283-90.
2003: T Baetz; Andrew R Belch; Stephen Couban; Kevin Imrie; J Yau; R Myers; Keyue Ding; N Paul; L Shepherd; J Iglesias; R Meyer; Michael Crump
Gemcitabine, dexamethasone and cisplatin is an active and non-toxic chemotherapy regimen in relapsed or refractory Hodgkin's disease: a phase II study by the National Cancer Institute of Canada Clinical Trials Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(12):1762-7.
2003: David C Hodgson; Richard W Tsang; Melania Pintilie; Alexander Sun; Woodrow Wells; Michael Crump; Mary K Gospodarowicz
Impact of chest wall and lung invasion on outcome of stage I-II Hodgkin's lymphoma after combined modality therapy.
International journal of radiation oncology, biology, physics 2003;57(5):1374-81.
2003: Nadine Tchen; Helen G Juffs; Fiona P Downie; Qi-Long Yi; Hanxian Hu; Irene Chemerynsky; Mark Clemons; Michael Crump; Paul E Goss; David Warr; Mary E Tweedale; Ian F Tannock
Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(22):4175-83.
2003: Richard W Tsang; Mary K Gospodarowicz; Melania Pintilie; Woodrow Wells; David C Hodgson; Alexander Sun; Michael Crump; Bruce J Patterson
Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(22):4157-64.
2003: Michael Crump; Dongsheng Tu; Lois Shepherd; Mark Levine; Vivien Bramwell; Kathleen Pritchard
Risk of acute leukemia following epirubicin-based adjuvant chemotherapy: a report from the National Cancer Institute of Canada Clinical Trials Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(16):3066-71.
2003: David C Hodgson; Jina Zhang-Salomons; Deanna M Rothwell; Lawrence Paszat; Richard W Tsang; Michael Crump; William J Mackillop
Evolution of treatment for Hodgkin's disease: a population-based study of radiation therapy use and outcome.
Clinical oncology (Royal College of Radiologists (Great Britain)) 2003;15(5):255-63.
2003: Zahir Hirji; Ronnie Saragosa; Helen Dedier; Michael Crump; Norman Franke; Lori L Burrows; Frances Jamieson; Shirley Brown; Michael Gardam
Contamination of bone marrow products with an actinomycete resembling Microbacterium species and reinfusion into autologous stem cell and bone marrow transplant recipients.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2003;36(10):e115-21.
2003: C Tom Kouroukis; Andrew R Belch; Michael Crump; Elizabeth Eisenhauer; Randy D Gascoyne; Ralph Meyer; Reinhard Lohmann; Pedro Lopez; Jean Powers; Robert Turner; Joseph Michael Connors
Flavopiridol in untreated or relapsed mantle-cell lymphoma: results of a phase II study of the National Cancer Institute of Canada Clinical Trials Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(9):1740-5.
2003: Kevin W Song; Peter Mollee; Armand Keating; Michael Crump
Autologous stem cell transplant for relapsed and refractory peripheral T-cell lymphoma: variable outcome according to pathological subtype.
British journal of haematology 2003;120(6):978-85.
2003: Lillian Sung; Rena Buckstein; John J Doyle; Michael Crump; Allan S Detsky
Treatment options for patients with acute myeloid leukemia with a matched sibling donor: a decision analysis.
Cancer 2003;97(3):592-600.
2002: Christine I Chen; D Roitman; Richard Tsang; A Keith Stewart; Armand Keating; Michael Crump
'Relative' chemotherapy sensitivity: the impact of number of salvage regimens prior to autologous stem cell transplant for relapsed and refractory aggressive non-Hodgkin's lymphoma.
Bone marrow transplantation 2002;30(12):885-91.
2002: Kevin W Song; Peter Mollee; Bruce Patterson; William Brien; Michael Crump
Pure red cell aplasia due to parvovirus following treatment with CHOP and rituximab for B-cell lymphoma.
British journal of haematology 2002;119(1):125-7.
2002: Peter Mollee; D Pereira; Tracy Nagy; Kevin Song; Ronnie Saragosa; Armand Keating; Michael Crump
Cyclophosphamide, etoposide and G-CSF to mobilize peripheral blood stem cells for autologous stem cell transplantation in patients with lymphoma.
Bone marrow transplantation 2002;30(5):273-8.
2002: Michael Crump; Stephen Couban; Ralph Meyer; Leona Rudinskas; Brent Zanke; Stefan Gluck; Andrew Maksymiuk; Paul Hoskins; Sarah Matthews; Elizabeth Eisenhauer
Phase II study of sequential topotecan and etoposide in patients with intermediate grade non-Hodgkin's lymphoma: a National Cancer Institute of Canada Clinical Trials Group study.
Leukemia & lymphoma 2002;43(8):1581-7.
2002: Yicheng Zhang; Michael Crump; Stuart A Berge
Purging of contaminating breast cancer cells from hematopoietic progenitor cell preparations using activation enhanced cell death.
Breast cancer research and treatment 2002;72(3):265-78.
2002: Joy Mangel; Rena Buckstein; Kevin Imrie; David E Spaner; Michael Crump; Kirsty Tompkins; Marciano Reis; Bayardo Perez-Ordonez; Sanjeev Deodhare; Robert Romans; Nancy Pennell; Jean B Robinson; Karen Hewitt; Patricia Richardson; Ana Lima; Peggy Pavlin; Neil L Berinstein
Immunotherapy with rituximab following high-dose therapy and autologous stem-cell transplantation for mantle cell lymphoma.
Seminars in oncology 2002;29(1 Suppl 2):56-69.
2002: Michael Crump
Inhibition of raf kinase in the treatment of acute myeloid leukemia.
Current pharmaceutical design 2002;8(25):2243-8.
2001: Richard W Tsang; Mary K Gospodarowicz; Melania Pintilie; Andrea Bezjak; Woodrow Wells; David C Hodgson; Michael Crump
Stage I and II MALT lymphoma: results of treatment with radiotherapy.
International journal of radiation oncology, biology, physics 2001;50(5):1258-64.
2001: Christine I Chen; Michael Crump; Richard Tsang; A Keith Stewart; Armand Keating
Autotransplants for histologically transformed follicular non-Hodgkin's lymphoma.
British journal of haematology 2001;113(1):202-8.
2001: C Doyle; Michael Crump; Melania Pintilie; Amit Oza
Does palliative chemotherapy palliate? Evaluation of expectations, outcomes, and costs in women receiving chemotherapy for advanced ovarian cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(5):1266-74.
2001: Christine I Chen; R Abraham; Richard Tsang; Michael Crump; Armand Keating; A Keith Stewart
Radiation-associated pneumonitis following autologous stem cell transplantation: predictive factors, disease characteristics and treatment outcomes.
Bone marrow transplantation 2001;27(2):177-82.
2000: A Patnaik; J MacKinnon; P Goss; T Nagy; K Stewart; Armand Keating; Michael Crump
Phase I/II trial of cyclophosphamide, mitoxantrone, and escalated doses of carboplatin supported by peripheral-blood stem cells in women with metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(12):2363-8.
2000: R Abraham; Tracy Nagy; P E Goss; Michael Crump
High dose chemotherapy and autologous blood stem cell support in women with breast carcinoma and isolated supraclavicular lymph node metastases.
Cancer 2000;88(4):790-5.
2000: Michael Crump; Kathleen Pritchard
High dose therapy with stem cell support for breast cancer: the jury is still out.
Cancer treatment and research 2000;103():115-36.
1999: Michael Crump; M Gospodarowicz; Frances A Shepherd
Lymphoma of the gastrointestinal tract.
Seminars in oncology 1999;26(3):324-37.
1999: Michael Crump; Jeff Lipton; David W Hedley; D Sutton; F Shepherd; Mark D Minden; K Stewart; S Beare; Elizabeth Eisenhauer
Phase I trial of sequential topotecan followed by etoposide in adults with myeloid leukemia: a National Cancer Institute of Canada Clinical Trials Group Study.
Leukemia 1999;13(3):343-7.
1999: Richard W Tsang; Mary K Gospodarowicz; SB Sutcliffe; Michael Crump; Armand Keating
Thoracic radiation therapy before autologous bone marrow transplantation in relapsed or refractory Hodgkin's disease. PMH Lymphoma Group, and the Toronto Autologous BMT Group.
European journal of cancer (Oxford, England : 1990) 1999;35(1):73-8.
1998: Aaron D Schimmer; A Keith Stewart; Armand Keating; J MacKinnon; Michael Crump; DM Sutton; Frances A Shepherd; Jacinta Meharchand
Safety of therapeutic anticoagulation in patients with multiple myeloma receiving autologous stem cell transplantation.
Bone marrow transplantation 1998;22(5):491-4.
1998: Aaron D Schimmer; M Quatermain; Kevin Imrie; Val Ali; Jan McCrae; A Keith Stewart; Michael Crump; C Derzko; Armand Keating
Ovarian function after autologous bone marrow transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(7):2359-63.
1998: Kevin R Imrie; Ian D Dubé; HM Prince; Caroline Girouard; Michael Crump; Armand Keating
New clonal karyotypic abnormalities acquired following autologous bone marrow transplantation for acute myeloid leukemia do not appear to confer an adverse prognosis.
Bone marrow transplantation 1998;21(4):395-9.
1998: Michael Crump; Stefan Gluck; Kathleen Pritchard; Lois Shepherd; Joseph L Pater
High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(2):800-2.
1997: FZ Al-Fiar; HM Prince; Kevin Imrie; A Keith Stewart; Michael Crump; Armand Keating
Bone marrow mononuclear cell count does not predict neutrophil and platelet recovery following autologous bone marrow transplant: value of the colony-forming unit granulocyte-macrophage (CFU-GM) assay.
Cell transplantation 1997;6(5):491-5.
1997: Caroline Girouard; J Dufresne; Kevin Imrie; A Keith Stewart; Joseph Brandwein; HM Prince; D Pantolony; Armand Keating; Michael Crump
Salvage chemotherapy with mini-BEAM for relapsed or refractory non-Hodgkin's lymphoma prior to autologous bone marrow transplantation.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(7):675-80.
1997: Michael Crump; Carol A Sawka; G DeBoer; R B Buchanan; J N Ingle; J Forbes; J W Meakin; W Shelley; Kathleen I Pritchard
An individual patient-based meta-analysis of tamoxifen versus ovarian ablation as first line endocrine therapy for premenopausal women with metastatic breast cancer.
Breast cancer research and treatment 1997;44(3):201-10.
1997: Kevin R Imrie; B Sheridan; R Colwill; Michael Crump; A Keith Stewart; Jan McCrae; R Danish; D Sutton; F Romeyer; Armand Keating
A phase I study of interleukin-6 after autologous bone marrow transplantation for patients with poor prognosis Hodgkin's disease.
Leukemia & lymphoma 1997;25(5-6):555-63.
1996: HM Prince; Michael Crump; K Imrie; A Keith Stewart; C Girouard; J M Brandwein; K Carstairs; D Pantalony; G Scott; SB Sutcliffe; D M Sutton; Richard Tsang; Armand Keating
Intensive therapy and autotransplant for patients with an incomplete response to front-line therapy for lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7(10):1043-9.
1996: G Liu; Michael Crump; Paul E Goss; J Dancey; Frances A Shepherd
Prospective comparison of the sclerosing agents doxycycline and bleomycin for the primary management of malignant pericardial effusion and cardiac tamponade.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(12):3141-7.
1996: Frances A Shepherd; R L Burkes; Y Cormier; Michael Crump; Ronald Feld; T Strack; M Schulz
Final results of the Canadian phase I dose escalation trial of gemcitabine and cisplatin for advanced non-small cell lung cancer.
Seminars in oncology 1996;23(5 Suppl 10):48-54.
1996: Frances A Shepherd; R Burkes; Y Cormier; Michael Crump; Ronald Feld; T Strack; M Schulz
Phase I dose-escalation trial of gemcitabine and cisplatin for advanced non-small-cell lung cancer: usefulness of mathematic modeling to determine maximum-tolerable dose.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(5):1656-62.
1996: Frances A Shepherd; Jean Latreille; Michael Crump; D Stewart; Eva Tomiak; Elizabeth Eisenhauer; B Fisher
Phase I study of paclitaxel (Taxol) and ifosfamide in previously untreated patients with advanced non-small-cell lung cancer. A study of the National Cancer Institute of Canada Clinical Trials Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7(3):311-3.
1996: HM Prince; K Imrie; Michael Crump; A Keith Stewart; C Girouard; R Colwill; J Brandwein; Richard W Tsang; J G Scott; D M Sutton; D Pantalony; K Carstairs; SB Sutcliffe; Armand Keating
The role of intensive therapy and autologous blood and marrow transplantation for chemotherapy-sensitive relapsed and primary refractory non-Hodgkin's lymphoma: identification of major prognostic groups.
British journal of haematology 1996;92(4):880-9.
1996: Frances A Shepherd; R Burkes; Y Cormier; Michael Crump; Ronald Feld; T Strack
Phase I trial of gemcitabine and cisplatin in advanced non-small cell lung cancer: a preliminary report.
Lung cancer (Amsterdam, Netherlands) 1996;14(1):135-44.
1996: Michael Crump; Paul E Goss; M Prince; C Girouard
Outcome of extensive evaluation before adjuvant therapy in women with breast cancer and 10 or more positive axillary lymph nodes.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(1):66-9.
1995: Paul E Goss; R Burkes; L Rudinskas; M King; W Chow; R Myers; M Davidson; P Poldre; Michael Crump; D Sutton
A phase II trial of prednisone, oral etoposide, and novantrone (PEN) as initial treatment of non-Hodgkin's lymphoma in elderly patients.
Leukemia & lymphoma 1995;18(1-2):145-52.
1995: Paul E Goss; R M Clark; U Ambus; H A Weizel; N A Wadden; Michael Crump; D Walde; L M Tye; R De Coster; J Bruynseels
Phase II study of vorozole (R83842), a new aromatase inhibitor, in postmenopausal women with advanced breast cancer in progression on tamoxifen.
Clinical cancer research : an official journal of the American Association for Cancer Research 1995;1(3):287-94.
1995: R Colwill; Michael Crump; F Couture; R Danish; A Keith Stewart; D M Sutton; J G Scott; SB Sutcliffe; J M Brandwein; Armand Keating
Mini-BEAM as salvage therapy for relapsed or refractory Hodgkin's disease before intensive therapy and autologous bone marrow transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(2):396-402.
1995: E W Winquist; J Laskey; Michael Crump; F Khamsi; Frances A Shepherd
Ketoconazole in the management of paraneoplastic Cushing's syndrome secondary to ectopic adrenocorticotropin production.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(1):157-64.
1995: HM Prince; S R Page; Armand Keating; R F Saragosa; N M Vukovic; K R Imrie; Michael Crump; A Keith Stewart
Microbial contamination of harvested bone marrow and peripheral blood.
Bone marrow transplantation 1995;15(1):87-91.
1995: M J Kovacs; Michael Crump; Armand Keating
Outpatient bone marrow harvesting: an update.
Bone marrow transplantation 1995;15(1):125-7.
1994: Paul E Goss; R Burkes; L Rudinskas; M King; W Chow; R Myers; M Davidson; P Poldre; Michael Crump; D Sutton
Prednisone, oral etoposide, and novantrone for treatment of non-Hodgkin's lymphoma: a preliminary report.
Seminars in hematology 1994;31(2 Suppl 3):23-9.
1993: Michael Crump; A M Smith; J Brandwein; F Couture; H Sherret; D M Sutton; J G Scott; Jan McCrae; C Murray; D Pantalony
High-dose etoposide and melphalan, and autologous bone marrow transplantation for patients with advanced Hodgkin's disease: importance of disease status at transplant.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(4):704-11.
1993: Michael Crump; F Couture; M Kovacs; R Saragosa; Jan McCrae; J Brandwein; L Huebsch; L Beauregard-Zollinger; Armand Keating
Interleukin-3 followed by GM-CSF for delayed engraftment after autologous bone marrow transplantation.
Experimental hematology 1993;21(3):405-410.
1992: Armand Keating; Michael Crump
High dose etoposide melphalan, total body irradiation and ABMT for acute myeloid leukemia in first remission.
Leukemia 1992;6 Suppl 4():90-1.
1992: Michael Crump; J M Brandwein; A M Smith; G R Langley; M J Burnell; L B Huebsch; S J Markman; K S Robinson; D M Sutton; H Solh
A regional autologous bone marrow transplant network: transfers to designated centers on the day after transplant.
Bone marrow transplantation 1992;9(6):445-50.
1991: Michael Crump; D M Sutton; D Pantalony
Sezary syndrome in a patient with hairy cell leukemia in remission.
Cancer 1991;68(4):829-33.
1990: Michael Crump; J M Brandwein; J G Scott; SB Sutcliffe; Armand Keating
Acute transient parotitis after high dose etoposide and autologous bone marrow transplantation.
Bone marrow transplantation 1990;6(4):259-61.